30 April 2020

Safety Alerts & Recalls for Pharmaceutical Products & Nutritional Supplements

Reference: CIR-2019-00000338

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Quarantine two batchs of pharmaceutical product XELODA FC Tablets 150mg
• Recall medical device SAPIEN 3 Ultra Delivery System
• Recall one batch of pharmaceutical product Ofev (nintedanib) 150mg capsule
• Safety alerts from using the Nutritional Supplement Bali Mojo Capsule
• Safety alerts from using the Nutritional Supplement Hong Kong Tianli Biological

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Quarantine two batchs of pharmaceutical product XELODA FC Tablets 150mg.pdf:

View Document

Recall medical device SAPIEN 3 Ultra Delivery System.pdf:

View Document

Recall one batch of pharmaceutical product Ofev (nintedanib) 150mg capsule.pdf:

View Document

Safety alerts from using the Nutritional Supplement Bali Mojo Capsule.pdf:

View Document

Safety alerts from using the Nutritional Supplement Hong Kong Tianli Biological.pdf:

View Document